MedPath

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Not Applicable
Recruiting
Conditions
Diabetes Mellitus, Type 2
Interventions
Dietary Supplement: Food Box Delivery
Behavioral: Digital Health Coaching
Behavioral: Diabetes Education Class
Behavioral: Remote Patient Monitoring (RPM)
Registration Number
NCT05288452
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

Brief Summary:

The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Detailed Description

Detailed Description:

1. FREEDOM Study (Type 2 Diabetes Mellitus):

The FREEDOM study is a 12-month clinical trial enrolling 304 Black adults with Type 2 Diabetes Mellitus across three healthcare systems in Alabama and Mississippi. Participants are randomly assigned to one of eight combinations of three intervention components:

* Digital Health Coaching: Participants receive one-on-one phone-based coaching for optimized diabetes management.

* Food Box Delivery: Food boxes are delivered every two weeks to participants' homes,

* Remote Patient Monitoring (RPM): Participants receive essential supplies, including glucometers, for remote blood glucose measurement. Data is monitored remotely for timely interventions.

The study involves three in-person visits at baseline, month 6, and month 12, as well as two telephone study check-ins at month 3 and 9. Survey packets are administered at each time point.

2. FREEDOM-HIV Study (Type 2 Diabetes Mellitus and HIV Cohort):

Additionally, a cohort within the study, known as the FREEDOM-HIV study, will enroll additional 80 adults who have both Type 2 Diabetes Mellitus and HIV. This cohort will be observed over a 6-month period and will also consist of the same three intervention components.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
304
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Arm 8Diabetes Education ClassRPM
Arm 7Diabetes Education ClassFood delivery
Arm 7Food Box DeliveryFood delivery
Arm 4Diabetes Education ClassDigital coaching+ RPM
Arm 6Diabetes Education ClassThe participant's will not receive any Intervention
Arm 1Digital Health CoachingDigital coaching+ Food delivery+ RPM
Arm 1Diabetes Education ClassDigital coaching+ Food delivery+ RPM
Arm 2Digital Health CoachingDigital coaching
Arm 2Diabetes Education ClassDigital coaching
Arm 4Remote Patient Monitoring (RPM)Digital coaching+ RPM
Arm 5Food Box DeliveryFood delivery+ RPM
Arm 5Remote Patient Monitoring (RPM)Food delivery+ RPM
Arm 1Food Box DeliveryDigital coaching+ Food delivery+ RPM
Arm 3Digital Health CoachingDigital coaching+ Food delivery
Arm 3Diabetes Education ClassDigital coaching+ Food delivery
Arm 4Digital Health CoachingDigital coaching+ RPM
Arm 5Diabetes Education ClassFood delivery+ RPM
Arm 1Remote Patient Monitoring (RPM)Digital coaching+ Food delivery+ RPM
Arm 3Food Box DeliveryDigital coaching+ Food delivery
Arm 8Remote Patient Monitoring (RPM)RPM
Primary Outcome Measures
NameTimeMethod
Primary Outcome for the HIV Cohort: Change in HbA1c level between baseline and 6 months6 months

The primary outcome of the study is to track change in the HbA1c between baseline and 6 months (endpoint of the study). The HbA1C will be tested at baseline and 6 months.

FREEDOM Study: Change in HbA1c level between baseline and 12 month12 months

The primary outcome of the study is to track change in the HbA1c between baseline and 12 months (endpoint of the study). The HbA1C will be tested at baseline, 6 and 12 months.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UAB Hospital and UMMC Cardiology Clinics

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath